Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin bolus reduction during postprandial continuous and intermittent exercise in adults with type 1 diabetes
PACTR202304590853621Not yet recruiting
- Sponsor
- URePSSS
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by URePSSS. Primary endpoint: Decrease in plasma glucose during exercise. Planned start May 2023; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on PACTR202304590853621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202304590853621.